Home/ Supplements/ Reishi/ Reishi Mushroom Extract-V

Reishi Mushroom Extract-V

product on market Capsule Douglas Laboratories Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade
Label

Product Label

Label for Reishi Mushroom Extract-V
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Vegetarian Capsule(s)
Serving Size
30
Servings
Non-Nutrient/Non-Botanical
Product Type
0%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Market median: 340.0mg (243 products) 3 studies — no high-quality reviews

Other Ingredients

Cellulose Rice Protein Vegetable Stearate
Claims

Label Claims — Verification

Unverified All Other
Info

Product Information

Directions for Use

Suggested Usage: As a dietary supplement, adults take 1 to 4 capsules, 1 to 3 times daily between meals as desired, or as advised by your healthcare professional. Take 500 to 1000 mg. vitamin C each time to increase absorption. If digestive irritation occurs, take with meals.

Warnings & Precautions

KEEP OUT OF REACH OF CHILDREN.

Note: If pregnant of nursing consult your healthcare professional before using this product.

Tamper resistant package, do not use if outer seal is missing.

Formulation Notes

4% triterpenes and 10% polysaccharides

Reishi (Ganoderma lucidum (Leyss.ex Fr.) P. Karst.) is the source of the triterpenes called ganoderic acids (similar to steroid hormones), has highly active polysaccharides, and contains ergosterols, complete protein, unsaturated fatty acids, vitamins and minerals. This extract is standardized at 4% triterpenes and 10% polysaccharides.

Standardized Herbal Extract

Additional Information

For optimal storage conditions, store in a cool, dry place. (59(0)-77(0)F/15(0)-25(0)C) (35-65% relative humidity)

Formula #77365

Metadata

Product Details

UPC / SKU3 10539 01327 4
DSLD Entry Date2012-01-25
Product TypeNon-Nutrient/Non-Botanical
FormCapsule
DSLD ID5190
Data Updated2026-04-11
Research

Research Evidence

6
Research Sources
60
Avg Quality
3
Meta Analysis
3
Rct
B Ganoderma lucidum mushroom for the treatment of cardiovascular risk factors
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
B Ganoderma lucidum (Reishi mushroom) for cancer treatment
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
B Ganoderma lucidum (Reishi mushroom) for cancer treatment
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
C Dynamic biomarkers indicate the immunological benefits provided by Ganoderma spore powder in post-operative breast and lung cancer patients
Rct Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2021 PubMed DOI
C Efficacy of Lingzhi or Reishi Medicinal Mushroom Ganoderma lucidum (Agaricomycetes) Supplementation on Psychological Stress and Selective Fitness Profile Parameters in Female College Students in West Bengal, India
Rct International journal of medicinal mushrooms 2024 PubMed DOI
C Preliminary Efficacy and Safety of Reishi & Privet Formula on Quality of Life Among Non-Small Cell Lung Cancer Patients Undergoing Chemotherapy: A Randomized Placebo-Controlled Trial
Rct Integrative cancer therapies 2020 PubMed DOI
View all evidence for Reishi →
Compare

Similar Products

View all Reishi products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.